PetMed Stock Based Compensation from 2010 to 2025

PETS Stock

USD 4.08 0.16 3.77%

PetMed Express Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2006-06-30

Previous Quarter

573 K

Current Value

452 K

Quarterly Volatility

1.2 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check PetMed Express financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PetMed Express' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.5 M, Interest Expense of 3.6 M or Selling General Administrative of 66.7 M, as well as many indicators such as Price To Sales Ratio of 0.29, Dividend Yield of 0.12 or PTB Ratio of 1.08. PetMed financial statements analysis is a perfect complement when working with PetMed Express Valuation or Volatility modules.

Check out the analysis of PetMed Express Correlation against competitors.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

Latest PetMed Express' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of PetMed Express over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. PetMed Express' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PetMed Express' overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

PetMed Stock Based Compensation Regression Statistics

	Arithmetic Mean	3,545,432
	Geometric Mean	1,931,666
	Coefficient Of Variation	71.50
	Mean Deviation	2,062,688
	Median	2,822,000
	Standard Deviation	2,535,094
	Sample Variance	6.4T
	Range	8.3M
	R-Value	0.92
	Mean Square Error	1.1T
	R-Squared	0.84
	Slope	487,429
	Total Sum of Squares	96.4T

PetMed Stock Based Compensation History

	2025	8.3 M
	2024	7.9 M
	2023	6.9 M
	2022	6.6 M
	2021	4.5 M
	2020	3.3 M
	2019	2.8 M

Other Fundumenentals of PetMed Express

Stock Based Compensation To Revenue

PetMed Express Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Good Will	Intangible Assets	Current Deferred Revenue	Net Tangible Assets	Deferred Long Term Liab	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		0.8	-0.73	0.7	0.91	0.72	0.81	0.78	-0.57	0.72	0.83	0.54	0.6	0.47	0.86	0.7	0.8	0.01	-0.29	0.36	0.51
Total Stockholder Equity	0.8		-0.93	0.97	0.54	0.68	0.33	0.97	-0.1	0.7	0.7	-0.02	0.06	0.7	0.79	0.48	0.41	0.44	0.25	-0.07	0.03
Net Debt	-0.73	-0.93		-0.92	-0.5	-0.5	-0.26	-0.93	0.03	-0.44	-0.67	0.15	0.05	-0.43	-0.82	-0.55	-0.35	-0.62	-0.4	0.25	0.13
Retained Earnings	0.7	0.97	-0.92		0.4	0.59	0.17	0.96	-0.07	0.66	0.59	-0.18	-0.12	0.69	0.68	0.37	0.23	0.58	0.4	-0.22	-0.13
Accounts Payable	0.91	0.54	-0.5	0.4		0.6	0.95	0.56	-0.6	0.5	0.74	0.72	0.77	0.21	0.79	0.74	0.84	-0.2	-0.51	0.5	0.68
Net Receivables	0.72	0.68	-0.5	0.59	0.6		0.55	0.61	-0.2	0.65	0.59	0.44	0.42	0.63	0.67	0.44	0.45	-0.15	-0.29	0.25	0.46
Total Liab	0.81	0.33	-0.26	0.17	0.95	0.55		0.33	-0.68	0.46	0.65	0.89	0.92	0.12	0.65	0.68	0.89	-0.46	-0.73	0.66	0.82
Total Current Assets	0.78	0.97	-0.93	0.96	0.56	0.61	0.33		-0.08	0.64	0.58	-0.06	0.03	0.66	0.77	0.47	0.36	0.51	0.31	-0.12	-0.01
Short Term Debt	-0.57	-0.1	0.03	-0.07	-0.6	-0.2	-0.68	-0.08		-0.48	-0.41	-0.71	-0.7	0.0	-0.21	-0.35	-0.61	0.39	0.61	-0.63	-0.64
Common Stock	0.72	0.7	-0.44	0.66	0.5	0.65	0.46	0.64	-0.48		0.53	0.35	0.39	0.87	0.38	0.25	0.49	-0.14	-0.25	0.33	0.37
Property Plant Equipment	0.83	0.7	-0.67	0.59	0.74	0.59	0.65	0.58	-0.41	0.53		0.41	0.47	0.3	0.81	0.68	0.74	-0.01	-0.23	0.28	0.39
Good Will	0.54	-0.02	0.15	-0.18	0.72	0.44	0.89	-0.06	-0.71	0.35	0.41		0.96	0.0	0.33	0.44	0.76	-0.76	-0.95	0.79	0.91
Intangible Assets	0.6	0.06	0.05	-0.12	0.77	0.42	0.92	0.03	-0.7	0.39	0.47	0.96		0.04	0.39	0.5	0.86	-0.72	-0.91	0.77	0.88
Current Deferred Revenue	0.47	0.7	-0.43	0.69	0.21	0.63	0.12	0.66	0.0	0.87	0.3	0.0	0.04		0.26	0.03	0.15	0.04	0.05	0.04	0.08
Net Tangible Assets	0.86	0.79	-0.82	0.68	0.79	0.67	0.65	0.77	-0.21	0.38	0.81	0.33	0.39	0.26		0.75	0.69	0.21	-0.06	0.21	0.37
Deferred Long Term Liab	0.7	0.48	-0.55	0.37	0.74	0.44	0.68	0.47	-0.35	0.25	0.68	0.44	0.5	0.03	0.75		0.66	0.05	-0.22	0.29	0.42
Capital Surpluse	0.8	0.41	-0.35	0.23	0.84	0.45	0.89	0.36	-0.61	0.49	0.74	0.76	0.86	0.15	0.69	0.66		-0.38	-0.63	0.64	0.71
Net Invested Capital	0.01	0.44	-0.62	0.58	-0.2	-0.15	-0.46	0.51	0.39	-0.14	-0.01	-0.76	-0.72	0.04	0.21	0.05	-0.38		0.92	-0.72	-0.73
Net Working Capital	-0.29	0.25	-0.4	0.4	-0.51	-0.29	-0.73	0.31	0.61	-0.25	-0.23	-0.95	-0.91	0.05	-0.06	-0.22	-0.63	0.92		-0.76	-0.84
Capital Stock	0.36	-0.07	0.25	-0.22	0.5	0.25	0.66	-0.12	-0.63	0.33	0.28	0.79	0.77	0.04	0.21	0.29	0.64	-0.72	-0.76		0.95
Long Term Investments	0.51	0.03	0.13	-0.13	0.68	0.46	0.82	-0.01	-0.64	0.37	0.39	0.91	0.88	0.08	0.37	0.42	0.71	-0.73	-0.84	0.95

Click cells to compare fundamentals

About PetMed Express Financial Statements

PetMed Express shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although PetMed Express investors may analyze each financial statement separately, they are all interrelated. The changes in PetMed Express' assets and liabilities, for example, are also reflected in the revenues and expenses on on PetMed Express' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	7.9 M	8.3 M
Stock Based Compensation To Revenue	0.02	0.02

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for PetMed Stock Analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PetMed Stock Based Compensation from 2010 to 2025

Latest PetMed Express' Stock Based Compensation Growth Pattern

PetMed Stock Based Compensation Regression Statistics

PetMed Stock Based Compensation History

Other Fundumenentals of PetMed Express

PetMed Express Stock Based Compensation component correlations

About PetMed Express Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for PetMed Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY